reader comments 100 with 78 posters participating Share this story When Amazon launched Amazon Care to its employees in 2019, the goal was to test the product before rolling it out nationwide. After that rollout happened earlier this year, Amazon CEO Andy Jassy told Insider that the expansion would “fundamentally” change the health care game ..
Enlarge / A tray of prepared syringes for booster vaccinations with Moderna’s vaccine. reader comments 147 with 80 posters participating Share this story Covid-19 Coverage View more stories Amid the stratospheric rise of the omicron variant, real-world data on the effectiveness of COVID-19 booster doses is now rolling in—and it is only looking up for ..
Enlarge / A tray of prepared syringes for booster vaccinations with Moderna’s vaccine. reader comments 153 with 90 posters participating Share this story Covid-19 Coverage View more stories The Food and Drug Administration has authorized booster doses of both the Pfizer-BioNTech and Moderna COVID-19 vaccines for all people ages 18 and up, the companies announced ..
Enlarge / Frontline workers of the Medical Center of Aurora gather in front of the hospital for a COVID-19 memorial in Aurora, Colorado, on July 15, 2021. reader comments 42 with 29 posters participating Share this story Covid-19 Coverage View more stories More states are activating crisis standards of care, and at least two have ..
Enlarge / The Food and Drug Administration headquarters in White Oak, Maryland. reader comments 175 with 96 posters participating Share this story Two leading vaccine regulators who had previously announced their resignations from the Food and Drug Administration have now come out against the Biden administration’s plan to offer COVID-19 booster shots. In a viewpoint ..
Enlarge / Empty Pfizer-BioNTech COVID-19 vaccine vials reader comments 229 with 131 posters participating Share this story Covid-19 Coverage View more stories The Food and Drug Administration has granted full approval of the Pfizer/BioNTech COVID-19 vaccine, which will now be marketed as Comirnaty (koe-mir’-na-tee), the agency announced Monday. The vaccine’s full approval—or Biologics License Application ..
Enlarge / Vials with COVID-19 Vaccine labels showing logos of pharmaceutical company Pfizer and German biotechnology company BioNTech. reader comments 180 with 96 posters participating Share this story The Food and Drug Administration is aiming to issue full regulatory approval of Pfizer/BioNTech’s COVID-19 vaccine as early as Monday, according to a report by the New ..
Enlarge / Pharmaceutical bottles on a conveyor belt in South Africa. reader comments 21 with 19 posters participating Share this story The Biden administration has thrown its weight behind an international effort to loosen patent and other legal protections for COVID vaccines. “The Administration believes strongly in intellectual property protections, but in service of ending ..
Michael Ciaglo | Getty Images reader comments 109 with 59 posters participating Share this story It’s late on a Tuesday night, and you’re running through your usual routine. You go through your social media, blocking everyone who has posted an ecstatic shot selfie. You check, and double-check, your state’s eligibility requirements. Maybe you monitor your ..
reader comments 133 with 100 posters participating Share this story Update 4 pm EDT: The board of experts monitoring the clinical trial of AstraZeneca’s COVID-19 vaccine determined that the vaccine is actually between 69 percent and 74 percent effective at preventing symptomatic disease—not 79 percent effective, as AstraZeneca announced Monday. According to a report by ..